Tag: CYP17A1 inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CYP17A1 inhibitors

Practical or political? CDC says frontline workers can get COVID-19 boosters | 2021-09-24 | BioWorld

Added to Collection on: 2021-09-24 17:48:45

Tags for this article:

Organic compounds

Drugs

Health care

Androstanes

Cancer treatments

CYP17A1 inhibitors

Steroidal antiandrogens

Click the tags to see associated articles and topics

View Article Details

How the FDA can make better decisions on drug safety | Chicago Booth Review

Added to Collection on: 2021-09-29 16:52:30

Tags for this article:

Food and Drug Administration

Statin

John R. Birge

Click the tags to see associated articles and topics

View Article Details

After a Scottish aye, NICE says no to Lynparza for prostate cancer - - Pharmaphorum

Added to Collection on: 2022-01-05 16:10:24

Tags for this article:

National Health Service

Institute of Cancer Research

Click the tags to see associated articles and topics

View Article Details

Xeris Biopharma Eyes High End Of FY21 Sales Outlook - Benzinga

Added to Collection on: 2022-01-18 15:41:41

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Similar efficacy, lower adverse event risk with lower doses of pioglitazone - Healio

Added to Collection on: 2022-03-23 02:01:55

Tags for this article:

Medroxyprogesterone acetate

Type 2 diabetes

Type 1 diabetes

Paresh Dandona

Click the tags to see associated articles and topics

View Article Details

5 of the most popular pharmaceutical class action lawsuits - FingerLakes1.com

Added to Collection on: 2022-05-19 16:00:32

Tags for this article:

Pharmaceuticals policy

Pharmaceutical industry

Takeda Pharmaceutical Company

Click the tags to see associated articles and topics

View Article Details

Improved outcome for prostate cancer patients in Phase III PROpel trial

Added to Collection on: 2022-06-22 14:46:48

Tags for this article:

Steroidal antiandrogens

Merck Research Laboratories

Click the tags to see associated articles and topics

View Article Details

AstraZeneca and MSD's Lynparza approved in the EU for prostate cancer

Added to Collection on: 2022-12-21 07:53:46

Tags for this article:

Steroidal antiandrogens

Click the tags to see associated articles and topics

View Article Details

ADRs End Higher, AstraZeneca and Carnival Trade Actively | Morningstar

Added to Collection on: 2022-12-21 23:29:59

Tags for this article:

The Bank of New York Mellon

Click the tags to see associated articles and topics

View Article Details

CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study ...

Added to Collection on: 2024-02-18 17:59:30

Tags for this article:

Prostate cancer

CYP17A1 inhibitors

Androstanes

Steroidal antiandrogens

5α-Reductase inhibitors

Abiraterone acetate

Antiandrogen

Androgen synthesis inhibitor

Δ4-Abiraterone

Medical uses of bicalutamide

AstraZeneca

Click the tags to see associated articles and topics

View Article Details

Tag: CYP17A1 inhibitors

Recent Related Articles to CYP17A1 inhibitors

Practical or political? CDC says frontline workers can get COVID-19 boosters | 2021-09-24 | BioWorld

How the FDA can make better decisions on drug safety | Chicago Booth Review

After a Scottish aye, NICE says no to Lynparza for prostate cancer - - Pharmaphorum

Xeris Biopharma Eyes High End Of FY21 Sales Outlook - Benzinga

Similar efficacy, lower adverse event risk with lower doses of pioglitazone - Healio

5 of the most popular pharmaceutical class action lawsuits - FingerLakes1.com

Improved outcome for prostate cancer patients in Phase III PROpel trial

AstraZeneca and MSD's Lynparza approved in the EU for prostate cancer

ADRs End Higher, AstraZeneca and Carnival Trade Actively | Morningstar

CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study ...

Create dashboard for Tag: CYP17A1 inhibitors